Condition: Follicular Lymphoma · Sponsor: The Lymphoma Academic Research Organisation
This study is a phase III, randomized, open-label, international, multicenter, interventional trial, designed to compare the efficacy and safety of mosunetuzumab in combination with lenalidomide versus anti-CD20 monoclonal antibody (mAb) plus chemotherapy in patients with previously untreated FLIPI 2-5 follicular lymphoma.
This description comes directly from the study's public registry record.
Anne FAUGIER · +33 4 72 66 93 33 · morninglyte@lysarc.org
Always discuss trial participation with your own doctor first.
| Krankenhaus der Barmherzigen Brüder Graz - Abteilung Für Innere Medizin I | Graz, Austria | Recruiting |
| Krems University Hospital - Abteilung Für Innere Medizin 2 | Krems, Austria | Recruiting |
| LKH HOCHSTEIERMARK - Department für Hämato-Onkologie | Leoben, Austria | Recruiting |
| Kepler Universitaetsklinikum - Univ.-Klinik für Hämatologie und Internistische Onkologie | Linz, Austria | Recruiting |
| Paracelsus Medical University - 3rd Medical Department | Salzburg, Austria | Recruiting |
| Univ. Klinikum ST.PÖLTEN - Klinische Abteilung Für Innere Medizin 1 | Sankt Pölten, Austria | Recruiting |
| Medical University of Vienna - Department of Hematology and Hemostaseology | Vienna, Austria | Recruiting |
| Klinikum Wels-Grieskirchen GMBH - IVth Internal Department | Wels, Austria | Recruiting |
| Universitätsklinikum Wiener Neustadt - Klinische Abteilung für Innere Medizin III | Wiener Neustadt, Austria | Withdrawn |
| AZ SINT-JAN BRUGGE - OOSTENDE AV - Service Hématologie | Bruges, Belgium | Recruiting |
| INSTITUT JULES BORDET - Service Hématologie | Brussels, Belgium | Recruiting |
| UNIVERSITE CATHOLIQUE DE LOUVAIN SAINT-LUC - Service Hématologie | Brussels, Belgium | Recruiting |
+ 104 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06284122